Skye Bioscience: Initial Ownership Filing by John P. Sharp
Ticker: SKYE · Form: 3 · Filed: Apr 29, 2026 · CIK: 0001516551
| Field | Detail |
|---|---|
| Company | Skye Bioscience, Inc. (SKYE) |
| Form Type | 3 |
| Filed Date | Apr 29, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, ownership
Related Tickers: SKYE
TL;DR
John Sharp just filed his initial ownership docs for Skye Bioscience (SKYE).
AI Summary
John P. Sharp filed an initial statement of beneficial ownership of securities (Form 3) for Skye Bioscience, Inc. on April 28, 2026. The filing indicates Sharp's initial holdings in the company, though specific share counts and dollar amounts are not detailed in this summary document.
Why It Matters
This filing marks the initial reporting of beneficial ownership for John P. Sharp, providing transparency on his stake in Skye Bioscience, Inc.
Risk Assessment
Risk Level: low — Form 3 filings are standard initial disclosures and do not inherently indicate risk.
Key Players & Entities
- John P. Sharp (person) — Reporting Person
- Skye Bioscience, Inc. (company) — Issuer
- 0001516551 (company) — Skye Bioscience, Inc. CIK
- 0001342894 (person) — John P. Sharp CIK
FAQ
What type of SEC filing is this?
This is a Form 3 - Initial statement of beneficial ownership of securities.
Who is the reporting person?
The reporting person is John P. Sharp.
What company is this filing related to?
The filing is related to Skye Bioscience, Inc.
When was this filing accepted by the SEC?
The filing was accepted on April 28, 2026.
What is the CIK for Skye Bioscience, Inc.?
The CIK for Skye Bioscience, Inc. is 0001516551.
Filing Details
This Initial Statement of Beneficial Ownership (Form 3) was filed with the SEC on April 29, 2026 by John P. Sharp regarding Skye Bioscience, Inc. (SKYE). Form 3 filings establish the initial ownership position of company insiders when they first assume their role.